Concepedia

Publication | Open Access

Safety and Efficacy of Burosumab in Pediatric Patients With X-Linked Hypophosphatemia: A Phase 3/4 Open-Label Trial

DOIFull Paper Access

17

Citations

19

References

2022

Year

Noriyuki Namba, Takuo Kubota, Koji Muroya, Hiroyuki Tanaka, Masanori Kanematsu, Masahiro Kojima, Shunichiro Orihara, Hironori Kanda, Yoshiki Seino, Keiichi Ozono
Journal of the Endocrine Society

Abstract

Burosumab has a good safety profile and is effective in pediatric patients with XLH.

References

YearCitations

Page 1